BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16948135)

  • 1. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies.
    Yamasaki Y; Honkanen-Scott M; Hernandez L; Ikeda K; Barker T; Bubb MR; Narain S; Richards HB; Chan EK; Reeves WH; Satoh M
    Arthritis Rheum; 2006 Sep; 54(9):3051-6. PubMed ID: 16948135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
    Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
    Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
    J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
    Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
    Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
    Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
    Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody to RNA polymerase I in scleroderma sera.
    Reimer G; Rose KM; Scheer U; Tan EM
    J Clin Invest; 1987 Jan; 79(1):65-72. PubMed ID: 2432091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
    Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
    Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
    Satoh T; Ishikawa O; Ihn H; Endo H; Kawaguchi Y; Sasaki T; Goto D; Takahashi K; Takahashi H; Misaki Y; Mimori T; Muro Y; Yazawa N; Sato S; Takehara K; Kuwana M
    Rheumatology (Oxford); 2009 Dec; 48(12):1570-4. PubMed ID: 19808694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
    Kuwana M; Kimura K; Kawakami Y
    Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay.
    Chang M; Wang RJ; Yangco DT; Sharp GC; Komatireddy GR; Hoffman RW
    Clin Immunol Immunopathol; 1998 Oct; 89(1):71-8. PubMed ID: 9756726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.
    Shah AA; Rosen A; Hummers L; Wigley F; Casciola-Rosen L
    Arthritis Rheum; 2010 Sep; 62(9):2787-95. PubMed ID: 20506513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.
    Kang EH; Im CH; Kim SH; Chung JR; Lee EY; Kim DJ; Lee EB; Song YW
    J Korean Med Sci; 2006 Dec; 21(6):1121-3. PubMed ID: 17179700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes.
    Kuwana M; Okano Y; Kaburaki J; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Feb; 42(2):275-84. PubMed ID: 10025921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis.
    Codullo V; Morozzi G; Bardoni A; Salvini R; Deleonardi G; De PitĂ  O; Riccieri V; Ruffatti A; Tincani A; Tozzoli R; Valesini G; Montecucco C;
    Clin Exp Rheumatol; 2007; 25(3):373-7. PubMed ID: 17631732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].
    Zabek J; Palacz A; Pyka J; Krzewska I
    Pol Arch Med Wewn; 2008; 118 Suppl():25-30. PubMed ID: 19562966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
    Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
    J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
    Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
    Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
    Kuwana M; Pandey JP; Silver RM; Kawakami Y; Kaburaki J
    J Rheumatol; 2003 Nov; 30(11):2392-7. PubMed ID: 14677183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.